切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2024, Vol. 13 ›› Issue (01) : 78 -82. doi: 10.3877/cma.j.issn.2095-3224.2024.01.013

病例报道

肛管直肠黑色素瘤10例临床分析并文献复习
施波1, 邰清亮1, 陈国梁1, 侍新宇1, 姚慧慧1, 陈俊杰1, 沈成龙2, 周国强2, 顾闻1, 刘峰3,(), 何宋兵1,()   
  1. 1. 215000 苏州大学附属第一医院普外科
    2. 215000 常熟市第二人民医院胃肠外科
    3. 215028 苏州永鼎医院普外科
  • 收稿日期:2023-06-16 出版日期:2024-02-25
  • 通信作者: 刘峰, 何宋兵
  • 基金资助:
    江苏省自然科学基金(No. BK20191172); 苏州市医工结合协同创新研究项目(No. SLJ2021007); 苏州市姑苏卫生重点人才项目(No. GSWS2020005)

Clinical analysis and review of 10 cases of anorectal malignant melanoma

Bo Shi1, Qingliang Tai1, Guoliang Chen1, Xinyu Shi1, Huihui Yao1, Junjie Chen1, Chenglong Shen2, Guoqiang Zhou2, Wen Gu1, Feng Liu3,(), Songbing He1,()   

  1. 1. Department of General Surgery, First Affiliated Hospital of Soochow University, Suzhou 215000, China
    2. Department of Gastrointestinal Surgery, Changshu No. 2 Hospital, Suzhou 215000, China
    3. Department of General Surgery, Suzhou Yongding Hospital, Suzhou 215028, China
  • Received:2023-06-16 Published:2024-02-25
  • Corresponding author: Feng Liu, Songbing He
引用本文:

施波, 邰清亮, 陈国梁, 侍新宇, 姚慧慧, 陈俊杰, 沈成龙, 周国强, 顾闻, 刘峰, 何宋兵. 肛管直肠黑色素瘤10例临床分析并文献复习[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(01): 78-82.

Bo Shi, Qingliang Tai, Guoliang Chen, Xinyu Shi, Huihui Yao, Junjie Chen, Chenglong Shen, Guoqiang Zhou, Wen Gu, Feng Liu, Songbing He. Clinical analysis and review of 10 cases of anorectal malignant melanoma[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(01): 78-82.

目的

探讨肛管直肠恶性黑色素瘤(ARMM)的临床病理特征及诊治方法。

方法

回顾性分析苏州大学附属第一医院2011~2021年间收治的ARMM10例并结合文献复习,对其临床资料、病理特点、治疗结果和预后情况进行探讨并总结诊治经验。

结果

10例ARMM患者中,男性4例,女性6例;年龄50~79岁,平均发病年龄(61.4±7.6)岁。患者临床表现多样,但以便血为主,缺乏特异性,所有患者术前行CEA,CA19-9定量检测结果均正常;10例患者中,9例行免疫组化染色,其中主要指标有S-100、HBM、MelanA、Ki-67,9例患者S-100均为阳性;HBM8例阳性;MelanA除4例未查外,4例阳性,1例阴性。9例患者Ki-67均为阳性,其中5例阳性区>50%。6例接受腹会阴联合肿瘤切除术(Miles术),4例接受经肛门直肠肿物切除术;5例术后接受综合治疗,1例术后因泌尿系转移行尿道切除术,4例术后未行辅助治疗。患者总体生存期5.5个月~108个月,平均生存(30.6±29.5)个月,中位生存期28.0个月。

结论

ARMM是一种临床上罕见且恶性程度极高的恶性肿瘤,临床表现不典型,主要通过病理活检来确诊,对于确诊患者行腹会阴联合切除是主要的手术方式,术后可以辅助放化疗和免疫治疗。

Objective

To investigate the clinicopathological features, diagnosis and treatment of anorectal malignant melanoma(ARMM).

Methods

From 2011 to 2021, ten cases of ARMM confirmed by pathological examination were analyzed retrospectively. Combined with relevant literature, we discussed the clinical data, pathological features, treatment results, prognosis and summarized the experience of diagnosis and treatment.

Results

Among the 10 patients with ARMM,four were males and 6 were females, with the age ranged from 50 to 79 years old, and the average age of (61.4±7.6) years. The clinical manifestations are diverse and non-specific, but mainly bloody stools. The results of CEA, CA19-9 quantitative detection were normal in all patients before operation. Immunohistochemistry was performed in 9 cases, we mainly tested S-100, HBM, MelanA, Ki-67. S-100 was positive in 9 cases, HBM was positive in 8 cases, MelanA was positive in 4 cases and negative in one case except 4 cases. Ki-67 was positive in 9 cases, of which 5 cases had a positive area > 50%. The 6 cases were submitted to abdominoperineal resection, and 4 cases were submitted to local resection of anorectal tumor. The 5 cases received multimodality therapy after operation, one case was submitted to urethrotomy because of urinary metastasis after operation, and 4 cases did not receive any therapy.The overall survival time of patients in this group was 5.5~108 months, the average time was (30.6±29.5) months, the median survival time was 28 months.

Conclusion

ARMM is a rare and highly malignant tumor with atypical clinical manifestations, which is mainly diagnosed by pathological biopsy,but digital anorectal examination plays an important role in the early detection of ARMM. Abdominoperineal resection is the main surgical method for confirmed patients. Radiotherapy, chemotherapy and immunotherapy can be supplemented.

表1 9例患者免疫组化主要指标染色结果
表2 10例ARMM患者的临床症状及预后分析
[1]
Nigam JS, Nishit, Kumar T, et al. Anorectal melanoma-brownish black mass not always a hemorrhoid [J]. J Gastrointest Cancer, 2022, 53(3): 825-829.
[2]
中国抗癌协会,中国抗癌协会大肠癌专业委员会.中国恶性肿瘤整合诊治指南-肛管癌部分[J/OL].中华结直肠疾病电子杂志, 2022, 11(1): 13-17.
[3]
王锡山.肛管直肠恶性黑色素瘤诊治指南解读[J/CD].中华结直肠疾病电子杂志, 2015, 4(2): 15-17.
[4]
中国临床肿瘤学会指南工作委员会.黑色素瘤诊疗指南2022[M].北京:人民卫生出版社, 2022.
[5]
曹龙磊,周启昌,于杰,等.老年肛管直肠恶性黑色素瘤、腺癌伴Paget病与鳞癌的复合癌一例[J].中华胃肠外科杂志, 2016, 19(12): 1434-1435.
[6]
Slingluff CLJr, Vollmer RT, Seigler HF. Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients [J]. Surgery, 1990, 107(1): 1-9.
[7]
Pessaux P, Pocard M, Elias D, et al. Surgical management of primary anorectal melanoma [J]. Br J Surg, 2004, 91(9): 1183-1187.
[8]
陈勇,叶红.肛管直肠恶性黑色素瘤6例临床病理学分析[J].肿瘤学杂志, 2017, 23(10): 928-930.
[9]
魏雪静,张彦宁,徐瑞,等.原发性消化道黑色素瘤14例临床病理分析[J].临床与实验病理学杂志, 2021, 37(6): 655-659.
[10]
邹振玉,刘海亮,孙培鸣,等.肛管直肠恶性黑色素瘤34例治疗与预后分析[J].中华胃肠外科杂志, 2013, 16(5): 459-462.
[11]
Tracey EH, Vij A. Updates in melanoma [J]. Dermatol Clin, 2019, 37(1): 73-82.
[12]
李燕,徐青,余静,等.肛管直肠原发性恶性黑色素瘤的CT和MRI诊断:2例报告并文献复习[J].医学影像学杂志, 2016, 26(1): 153-156.
[13]
Puglisi R, Bellenghi M, Pontecorvi G, et al. Biomarkers for diagnosis, prognosis and response to immunotherapy in melanoma[J]. Cancers (Basel), 2021, 13(12): 2875.
[14]
Eisenstein A, Gonzalez EC, Raghunathan R, et al. Emerging biomarkers in cutaneous melanoma[J]. Mol Diagn Ther, 2018, 22(2): 203-218.
[15]
栾立鹏,陈俊杰,顾闻,等.直肠肛管恶性黑色素瘤1例报告[J].中国血液流变学杂志, 2019, 29(3): 277-280, 302.
[16]
张森,高枫,陈利生,等.直肠肛管恶性黑色素瘤的临床特征分析[J].中华胃肠外科杂志, 2005, 8(4): 309-311.
[17]
Iddings DM, Fleisig AJ, Chen SL, et al. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? [J]. Ann Surg Oncol, 2010, 17(1): 40-44.
[18]
Jaiswal BS, Janakiraman V, Kljavin NM, et al. Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors[J]. PLoS One, 2009, 4(5): e5717.
[19]
Ascierto PA, Kirkwood JM, Grob JJ, et al. The role of BRAF V600 mutation in melanoma [J]. J Transl Med, 2012, 10: 85.
[20]
O'Donnell JS, Long GV, Scolyer RA, et al. Resistance to PD1/PDL1 checkpoint inhibition[J]. Cancer Treat Rev, 2017, 52: 71-81.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[3] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[4] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 杨建波, 马欢, 黄小梅, 刘华柱. 结肠镜辅助下EMR、CSP和RFA术治疗直径<1cm结直肠息肉的疗效和安全性比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 76-79.
[8] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[9] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[10] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[11] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[12] 王湛, 李文坤, 杨奕, 徐芳, 周敏思, 苏珈仪, 王亚丹, 吴静. 炎症指标在早发性结直肠肿瘤中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 802-810.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 刘福成, 赵欣, 乔海朋, 刘晓峰, 张翀, 张宗明. 保留左结肠动脉的肠系膜下动脉根部淋巴结清扫对腹腔镜直肠癌根治术的疗效影响[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 647-653.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?